Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
87.16
+1.24 (1.44%)
At close: Aug 7, 2026, 4:00 PM EDT
87.16
0.00 (0.00%)
Pre-market: Aug 10, 2026, 5:30 AM EDT
Medtronic Revenue
In the fiscal year ending April 24, 2026, Medtronic had annual revenue of $36.36B with 8.43% growth. Medtronic had revenue of $9.81B in the quarter ending April 24, 2026, with 9.86% growth.
Revenue (ttm)
$36.36B
Revenue Growth
+8.43%
P/S Ratio
3.07
Revenue / Employee
$382,779
Employees
95,000
Market Cap
111.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 24, 2026 | 36.36B | 2.83B | 8.43% |
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
| Apr 26, 2019 | 30.56B | 604.00M | 2.02% |
| Apr 27, 2018 | 29.95B | 243.00M | 0.82% |
| Apr 28, 2017 | 29.71B | 877.00M | 3.04% |
| Apr 29, 2016 | 28.83B | 8.57B | 42.31% |
| Apr 24, 2015 | 20.26B | 3.26B | 19.15% |
| Apr 25, 2014 | 17.01B | 415.00M | 2.50% |
| Apr 26, 2013 | 16.59B | 406.00M | 2.51% |
| Apr 27, 2012 | 16.18B | 676.00M | 4.36% |
| Apr 29, 2011 | 15.51B | 116.00M | 0.75% |
| Apr 30, 2010 | 15.39B | 793.00M | 5.43% |
| Apr 24, 2009 | 14.60B | 1.08B | 8.02% |
| Apr 25, 2008 | 13.52B | 1.22B | 9.89% |
| Apr 27, 2007 | 12.30B | 1.01B | 8.92% |
| Apr 28, 2006 | 11.29B | 1.24B | 12.30% |
| Apr 29, 2005 | 10.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 46.59B |
| Stryker | 25.84B |
| GE HealthCare Technologies | 21.27B |
| Boston Scientific | 21.00B |
| Koninklijke Philips | 20.18B |
| Zimmer Biomet Holdings | 8.51B |
| Edwards Lifesciences | 6.51B |
| Smith & Nephew | 6.30B |
MDT News
- 1 day ago - I've Got Royalty on the Brain - ETF Trends
- 3 days ago - Medtronic announces CE Mark indication for Affera Mapping and Ablation System - TheFly
- 3 days ago - 33 stocks to bet on foreign markets continuing to beat the S&P 500 - Market Watch
- 3 days ago - Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias - PRNewsWire
- 4 days ago - Medtronic put volume heavy and directionally bearish - TheFly
- 12 days ago - Medtronic upgraded to Buy from Neutral at UBS - TheFly
- 19 days ago - A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - PRNewsWire
- 20 days ago - Medtronic to announce financial results for its first quarter of fiscal year 2027 - PRNewsWire